(LYSX) Multi Units France - Lyxor - Ratings and Ratios
ETF, Eurozone, Blue-chip, Equity, Index
Description: LYSX Multi Units France - Lyxor
The Lyxor EURO STOXX50 (DR) UCITS ETF is designed to replicate the performance of the EURO STOXX50 Net Return EUR index, a premier benchmark for Eurozone blue-chip stocks. By tracking this index, the ETF provides investors with exposure to 50 leading stocks across 12 Eurozone countries, covering approximately 60% of the free float market capitalization of the EURO STOXX Total Market Index.
The EURO STOXX50 index is a widely recognized benchmark for the Eurozones largest and most liquid stocks, offering a diversified portfolio of supersector leaders. With a UCITS-compliant structure, the Lyxor EURO STOXX50 (DR) UCITS ETF adheres to stringent regulatory standards, ensuring a high level of investor protection.
From a technical analysis perspective, the ETFs price is currently at 59.33, slightly below its 20-day simple moving average (SMA) of 59.76. However, it is above its 50-day SMA of 57.39 and 200-day SMA of 55.50, indicating a potential bullish trend. The average true range (ATR) is 0.60, representing a 1.02% daily volatility. Given the current technical setup, a potential price target could be the 52-week high of 60.36, with a stop-loss around 57.00.
Fundamentally, the ETF has a substantial assets under management (AUM) of 2429.17M EUR, indicating a high level of investor confidence and liquidity. Considering the current market conditions and the ETFs underlying index, a forecast for the Lyxor EURO STOXX50 (DR) UCITS ETF could be a gradual increase in price, potentially reaching 62.00 in the next 6-12 months, driven by the overall performance of the Eurozones blue-chip stocks and a potential strengthening of the European economy.
Combining technical and fundamental analysis, the outlook for LYSX appears positive, with a potential upside driven by both chart patterns and underlying market fundamentals. Investors should, however, remain vigilant and monitor both the ETFs price action and the overall Eurozone market conditions to adjust their strategies accordingly.
Additional Sources for LYSX ETF
LYSX ETF Overview
| Market Cap in USD | 4,181m |
| Category | Eurozone Large-Cap Equity |
| TER | 0.20% |
| IPO / Inception | 2001-02-19 |
LYSX ETF Ratings
| Growth Rating | 75.9 |
| Fundamental | - |
| Dividend Rating | 3.54 |
| Rel. Strength | -1.88 |
| Analysts | - |
| Fair Price Momentum | 57.25 EUR |
| Fair Price DCF | - |
LYSX Dividends
Currently no dividends paidLYSX Growth Ratios
| Growth Correlation 3m | 47% |
| Growth Correlation 12m | 78.3% |
| Growth Correlation 5y | 90.9% |
| CAGR 5y | 12.79% |
| CAGR/Max DD 5y | 0.55 |
| Sharpe Ratio 12m | 1.43 |
| Alpha | 2.14 |
| Beta | 0.601 |
| Volatility | 12.66% |
| Current Volume | 2k |
| Average Volume 20d | 45.8k |
| Stop Loss | 57.6 (-3.5%) |
As of July 15, 2025, the stock is trading at EUR 59.68 with a total of 2,029 shares traded.
Over the past week, the price has changed by +0.81%, over one month by +1.90%, over three months by +11.72% and over the past year by +11.05%.
Yes. Based on ValueRay's Analyses, Multi Units France - Lyxor (XETRA:LYSX) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 75.94 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LYSX is around 57.25 EUR . This means that LYSX is currently overvalued and has a potential downside of -4.07%.
Multi Units France - Lyxor has no consensus analysts rating.
According to our own proprietary Forecast Model, LYSX Multi Units France - Lyxor will be worth about 64.9 in July 2026. The stock is currently trading at 59.68. This means that the stock has a potential upside of +8.76%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 64.9 | 8.8% |